@article{11033,
  keywords = {CPRD Aurum, Cprd gold, clinical practice research datalink, data quality, Validation, shares of Amgen Inc. Jick, Vasilakis-Scaramozza, Persson, and Hagberg are, employees of Boston Collaborative Drug Surveillance program which receives, industry funding to conduct research using CPRD data. The authors report no other, conflicts of interest in this work.},
  author = {S. Jick and C. Vasilakis-Scaramozza and R. Persson and D. Neasham and G. Kafatos and K. Hagberg},
  title = {Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments},
  year = {2023},
  journal = {Clin Epidemiol},
  volume = {15},
  edition = {2023/12/21},
  pages = {1219-1222},
  isbn = {1179-1349 (Print)
1179-1349},
  doi = {10.2147/clep.s434832},
  note = {1179-1349
Jick, Susan
Orcid: 0000-0002-2215-1067
Vasilakis-Scaramozza, Catherine
Orcid: 0000-0002-8721-4604
Persson, Rebecca
Orcid: 0000-0003-2979-3238
Neasham, David
Kafatos, George
Orcid: 0000-0001-7871-9216
Hagberg, Katrina Wilcox
Orcid: 0000-0002-2407-2995
Journal Article
New Zealand
Clin Epidemiol. 2023 Dec 16;15:1219-1222. doi: 10.2147/CLEP.S434832. eCollection 2023.},
  language = {eng},
}